Mutual Fund Details

SBI Healthcare Opportunities Fund Direct Plan-Growth

Name: SBI Healthcare Opportunities Fund Direct Plan-Growth
Brand: SBI Mutual Fund

Equity Pharma

NAV

₹484.1621

as on 20 Dec 2024, 09:00 PM

₹-4.3869(0.90%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

32.62%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

31.50%

Mirae Asset Healthcare Fund Direct - Growth

30.71%

SBI Healthcare Opportunities Fund Direct Plan-Growth

30.65%

UTI Healthcare Fund Direct-Growth

28.88%

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,96,223

₹2,02,611

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹1,02,611

Profit (absolute return)

102.61%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

1.79%

In the last 6 months

20.09%

In the last 1 year

45.58%

In the last 3 years

102.61%

In the last 5 years

281.19%

In the last 10 years

313.36%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

SBI Healthcare Opportunities Fund Direct Plan-Growth

as of 30 Nov 2024, 05:30 AM

₹3,459.68 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 15 days

0.89%

Expense Ratio

Plan

Growth

3.50%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 15 days

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

93.17%

₹3,223.39 Cr

Cash Holding

3.50%

₹121.09 Cr

Chemicals

3.33%

₹115.21 Cr

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

93.17%

₹3,223.39 Cr

Cash Holding

3.50%

₹121.09 Cr

Chemicals

3.33%

₹115.21 Cr

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹476.74 Cr

Max Healthcare Institute Ltd.

7.67%

₹265.36 Cr

Divi's Laboratories Ltd.

6.66%

₹230.41 Cr

Cipla Ltd.

6.65%

₹230.07 Cr

Lonza Group Ag

4.94%

₹170.91 Cr

Others

60.30%

₹2,086.19 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹476.74 Cr

Max Healthcare Institute Ltd.

7.67%

₹265.36 Cr

Divi's Laboratories Ltd.

6.66%

₹230.41 Cr

Cipla Ltd.

6.65%

₹230.07 Cr

Lonza Group Ag

4.94%

₹170.91 Cr

Others

60.30%

₹2,086.19 Cr

View All

Funds in this Category

This fund's returns:

26.51%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About SBI Healthcare Opportunities Fund Direct Plan-Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹3,459.68 Crores and the latest NAV decalared is ₹484.162 as on 22 Dec 2024 at 10:44 am.

SBI Healthcare Opportunities Fund Direct Plan-Growth scheme return performance in last 1 year is 45.58%, in last 3 years is 102.61% and 704.26% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.